Cyclosporine A does not prevent second-eye involvement in Leber’s hereditary optic neuropathy

BACKRGROUND: Evaluation of the efficacy of oral cyclosporine A as a prophylactic agent in preventing second-eye involvement in Leber’s hereditary optic neuropathy (LHON) in a prospective, open-label, non-randomized, multicenter pilot study. Only LHON patients aged 18 years or more, with confirmed pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Leruez, Stéphanie, Verny, Christophe, Bonneau, Dominique, Procaccio, Vincent, Lenaers, Guy, Amati-Bonneau, Patrizia, Reynier, Pascal, Scherer, Clarisse, Prundean, Adriana, Orssaud, Christophe, Zanlonghi, Xavier, Rougier, Marie-Bénédicte, Tilikete, Caroline, Miléa, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816422/
https://www.ncbi.nlm.nih.gov/pubmed/29454364
http://dx.doi.org/10.1186/s13023-018-0773-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816422/
https://www.ncbi.nlm.nih.gov/pubmed/29454364
http://dx.doi.org/10.1186/s13023-018-0773-y

Ejemplares similares